Search - tctmd.com

Displaying 321 - 340 of 444

Sort: Relevancy | Date

Presentation TCT 2013

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Presenter: Edoardo Camenzind

October 31, 2013

Presentation TCT 2013

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

Presenter: Dean Kereiakes

October 31, 2013

Presentation TCT 2013

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

Presenter: Peter Wenaweser

October 31, 2013

News Conference News TCT 2013

OPTIMIZE: 3-Month DAPT Safe with ZES

October 31, 2013

News Industry News

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

October 31, 2013

News Industry News

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

October 31, 2013

News Industry News

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

October 31, 2013

News Industry News

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

October 31, 2013

Presentation TCT 2013

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

Presenter: Roxana Mehran

October 30, 2013

News Conference News TCT 2013

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

October 30, 2013

Presentation

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

Presenter: Stephan Windecker

October 29, 2013

News Industry News

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

October 29, 2013

Presentation TCT 2013

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Presenter: Eugenia Nikolsky

October 28, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Conference News TCT 2013

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

October 28, 2013

Presentation

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Presenter: Gianluca Campo

October 23, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

L.A. McKeown

October 11, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

Advertisement

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

The DAPT Duration Dilemma: Recent Trials and Reasonable Guidelines for Clinical Practice

OPTIMIZE and ARTIC-INTERRUPTION: Perspectives on DAPT Duration after PCI

OPTIMIZE: 3-Month DAPT Safe with ZES

New Study Finds Patients who are Event-Free Following PCI at One Year May Not Need Prolonged Dual Antiplatelet Therapy

New Study Demonstrates Potential Benefits of Shorter-Term Dual Antiplatelet Therapy in Patients Treated With a Second Generation Drug-Eluting Stent

Genetic Profiling May Provide Clinical Benefit by Identifying Heart Attack Patients That Are Resistant to Blood Thinners

BioFreedom™ Continues to Demonstrate Comparable Long-Term Safety and Efficacy to Conventional DES

The Ongoing Saga of Short DAPT Therapy After DES: Navigating Device Evolution, New Pharmacotherapy, and Changing Clinical Practice Standards

PROTECT: ZES Lowers Thrombosis Rates Over SES at 4 Years

Mini-Review of the Latest ACC/AHA and ESC Guidelines on DAPT and PCI

OrbusNeich’s COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Cre8, BioFreedom Polymer-Free DES Show Promise

COMFORTABLE AMI: Biolimus-Eluting Stent Bests BMS in STEMI

Short- vs. Long-term Duration of DAPT in Patients Treated for In-Stent Restenosis

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Study Challenges Guidelines Regarding Delay for Noncardiac Surgery After PCI

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content